Anthropic Plans IPO, Positioning as Safe Superintelligence Leader
Published 11 h ago2 sourcesEvidence: Reported
Yicura BioMed, a Hong Kong Science Park biotech, plans an IPO in the city as soon as practicable, CEO Xian Jin said. Jin argues Hong Kong's biotech ecosystem lacks patient capital and commercialization talent, a recurring theme for the sector. The IPO signals continued but cautious capital-market activity in Hong Kong biotech.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 11 h ago2 sourcesEvidence: Reported
Published 20 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Unknown
Published 2 d ago2 sourcesEvidence: Reported
Published 3 h ago2 sourcesEvidence: Reported
Published 3 d ago1 sourceEvidence: Unknown
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported